Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Goodwill: 2024-2025

Historic Goodwill for ImmunityBio (IBRX) over the last 1 years, with Sep 2025 value amounting to $910,000.

  • ImmunityBio's Goodwill rose 1.11% to $910,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $910,000, marking a year-over-year increase of 1.11%. This contributed to the annual value of $910,000 for FY2024, which is N/A change from last year.
  • ImmunityBio's Goodwill amounted to $910,000 in Q3 2025, which was down 0.00% from $910,000 recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Goodwill peaked at $910,000 during Q4 2024, and registered a low of $900,000 during Q3 2024.
  • For the 2-year period, ImmunityBio's Goodwill averaged around $908,000, with its median value being $910,000 (2025).
  • Data for ImmunityBio's Goodwill shows a peak YoY climbed of 1.11% (in 2025) over the last 5 years.
  • ImmunityBio's Goodwill (Quarterly) stood at $910,000 in 2024, then increased by 1.11% to $910,000 in 2025.
  • Its Goodwill stands at $910,000 for Q3 2025, versus $910,000 for Q2 2025 and $910,000 for Q1 2025.